Page last updated: 2024-09-05

2,10,11-trihydroxy-n-n-propylnoraporphine and raclopride

2,10,11-trihydroxy-n-n-propylnoraporphine has been researched along with raclopride in 1 studies

Compound Research Comparison

Studies
(2,10,11-trihydroxy-n-n-propylnoraporphine)
Trials
(2,10,11-trihydroxy-n-n-propylnoraporphine)
Recent Studies (post-2010)
(2,10,11-trihydroxy-n-n-propylnoraporphine)
Studies
(raclopride)
Trials
(raclopride)
Recent Studies (post-2010) (raclopride)
6011,802132419

Protein Interaction Comparison

ProteinTaxonomy2,10,11-trihydroxy-n-n-propylnoraporphine (IC50)raclopride (IC50)
D(2) dopamine receptorHomo sapiens (human)0.052
D(2) dopamine receptorMus musculus (house mouse)0.032
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0279

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, E; Chu, TC; Potter, DE1

Other Studies

1 other study(ies) available for 2,10,11-trihydroxy-n-n-propylnoraporphine and raclopride

ArticleYear
Potential sites of action of TNPA: a dopamine-2 receptor agonist.
    Experimental eye research, 1999, Volume: 69, Issue:6

    Topics: Administration, Topical; Analysis of Variance; Animals; Aporphines; Aqueous Humor; Chromatography, High Pressure Liquid; Ciliary Body; Depression, Chemical; Dopamine Agonists; Dopamine Antagonists; Immunohistochemistry; Intraocular Pressure; Norepinephrine; Rabbits; Raclopride; Receptors, Dopamine D2; Sympathectomy

1999